Verona Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

21.02.2023 - LONDON and RALEIGH, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) - Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial ...

Related Keywords

United States ,United Kingdom ,Kimberly Minarovich Carrie Mckim ,Verona Pharma ,Strategic Communications ,International Media ,Kingdom Tel ,Senior Director ,Investor Relations ,Carrie Mckim ,European Investor Enquiries ,Richard Staines ,